S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

LEXXW Lexaria Bioscience Corporation

0.664

0.054 (8.85%)

Last Updated: 06:12:46

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Lexaria Bioscience (NASDAQ:LEXXW)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience (NASDAQ:LEXXW)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience Corporation News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 11 January 2025 (14 minutes ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 7 January 2025 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 4 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 19 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Wednesday 18 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Tuesday 17 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 6 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 27 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 19 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 17 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 3 October 2024 (3 months ago) • Edgar (US Regulatory)

More Lexaria Bioscience Corporation News Articles

JP Morgan Chase

Verizon Communications

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions